Radiology's value chain

Radiology

Volumn 263, Issue 1, 2012, Pages 243-252

  Enzmann, Dieter R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; HEALTH CARE COST; HEALTH SERVICE; IMAGE ANALYSIS; IMAGE DISPLAY; IMAGE PROCESSING; INFORMATION TECHNOLOGY; MEDICAL DECISION MAKING; MEDICAL INFORMATION; PRIORITY JOURNAL; PRODUCTIVITY; PROFESSIONAL COMPETENCE; PROFESSIONAL KNOWLEDGE; PROFESSIONAL PRACTICE; RADIOLOGIST; DECISION MAKING; ECONOMICS; FORECASTING; HEALTH CARE POLICY; HUMAN; MANAGEMENT; NONBIOLOGICAL MODEL; ORGANIZATION; ORGANIZATION AND MANAGEMENT; RADIOLOGY;

DECISION MAKING; EFFICIENCY, ORGANIZATIONAL; FORECASTING; HEALTH CARE REFORM; HUMANS; MODELS, ORGANIZATIONAL; ORGANIZATIONAL CULTURE; ORGANIZATIONAL INNOVATION; ORGANIZATIONAL OBJECTIVES; PRACTICE MANAGEMENT, MEDICAL; RADIOLOGY;

EID: 84861325207     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.12110227     Document Type: Article

References (36)

1. Anderson C. The end of theory: the data deluge makes the scientific method obsolete. Wired Magazine. June 23, 2008; issue 16.07.
2. Christensen CM, Grossman JH, Hwang J. The innovator's prescription: a disruptive solution for health care. New York, NY: McGraw-Hill, 2009; xxxix-xl, 2-11, 16, 100-101, 124.
3. Johnson MW, Christensen CM, Kagermann H. Reinventing your business model. Harv Bus Rev 2008;86(12):51-59.
4. Sowell T. Basic economics: a citizen's guide to the economy (revised and expanded edition). ed 2 New York, NY: Basic Books, 2004;156-157.
5. Spence M. The next convergence: the future of economic growth in a multispeed world. New York, NY: Garrar, Straus & Giroux, 2011; 29, 226, 227, 231.
6. IBM's centenary: the test of time. The Economist. June 11, 2011; 20.
7. McGahan AM. How industries change. Harv Bus Rev 2004;82(10):86-94, 156.
8. Pope WB, Lai A, Mehta R, et al. Apparent diffusion coefficient histogram analysis stratifies progression-free survival in newly diagnosed bevacizumab-treated glioblastoma. AJNR Am J Neuroradiol 2011;32(5):882-889.
9. Ellingson BM, Malkin MG, Rand SD, et al. Volumetric analysis of functional diffusion maps is a predictive imaging biomarker for cytotoxic and anti-angiogenic treatments in malignant gliomas. J Neurooncol 2011;102(1):95-103.
10. Kessler A. The end of medicine: how Silicon Valley (and naked mice) will reboot your doctor. New York, NY: HarperCollins, 2006;111-112.
11. Christensen CM. The innovator's solution: creating and sustaining a successful growth. Cambridge, Mass: Harvard Business School Publishing, 2003; 16, 10, 33.
12. Christensen CM. The innovator's dilemma: the revolutionary book that will change the way you do business. Cambridge, Mass: Harvard Business School Publishing, 1997;xxii, 178.
13. Ellingson BM, LaViolette PS, Rand SD, et al. Spatially quantifying microscopic tumor invasion and proliferation using a voxelwise solution to a glioma growth model and serial diffusion MRI. Magn Reson Med 2011;65(4):1131-1143.
14. Ellingson BM, Cloughesy TF, Lai A, Nghiemphu PL, Mischel PS, Pope WB. Quantitative volumetric analysis of conventional MRI response in recurrent glioblastoma treated with bevacizumab. Neuro-oncol 2011;13(4):401-409.
15. Ellingson BM, Cloughesy TF, Lai A, Nghiemphu PL, Liau LM, Pope WB. High order diffusion tensor imaging in human glioblastoma. Acad Radiol 2011;18(8):947-954.
16. Ellingson BM, Cloughesy TF, Lai A, Nghiemphu PL, Pope WB. Cell invasion, motility, and proliferation level estimate (CIMPLE) maps derived from serial diffusion MR images in recurrent glioblastoma treated with bevacizumab. J Neurooncol 2011;105(1):91-101.
17. Kim HJ, Brown M, Elashoff R, et al. Quantitative texture-based assessment of one-year changes in fibrotic reticular patterns on HRCT in scleroderma lung disease treated with oral cyclophosphamide. Eur Radiol 2011;21(12):2455-2465.
18. Segal E, Sirlin CB, Ooi C, et al. Decoding global gene expression programs in liver cancer by noninvasive imaging. Nat Biotechnol 2007;25(6):675-680. (Pubitemid 46897204)
19. Kuo MD, Gollub J, Sirlin CB, Ooi C, Chen X. Radiogenomic analysis to identify imaging phenotypes associated with drug response gene expression programs in hepatocellular carcinoma. J Vasc Interv Radiol 2007;18(7):821-831.
20. Diehn M, Nardini C, Wang DS, et al. Identification of noninvasive imaging surrogates for brain tumor gene-expression modules. Proc Natl Acad Sci U S A 2008;105(13):5213-5218. (Pubitemid 351738536)
21. Rutman AM, Kuo MD. Radiogenomics: creating a link between molecular diagnostics and diagnostic imaging. Eur J Radiol 2009;70(2):232-241.
22. Guccione S, Yang YS, Shi G, Lee DY, Li KCP, Bednarski MD. Functional genomics guided with MR imaging: mouse tumor model study. Radiology 2003;228(2):560-568. (Pubitemid 36910103)
23. Carlson MRJ, Pope WB, Horvath S, et al. Relationship between survival and edema in malignant gliomas: role of vascular endothelial growth factor and neuronal pentraxin 2. Clin Cancer Res 2007;13(9):2592-2598. (Pubitemid 46788024)
24. Pope WB, Chen JH, Dong J, et al. Relationship between gene expression and enhancement in glioblastoma multiforme: exploratory DNA microarray analysis. Radiology 2008;249(1):268-277.
25. Gravendeel LA, Kouwenhoven MC, Gevaert O, et al. Intrinsic gene expression profiles of gliomas are a better predictor of survival than histology. Cancer Res 2009;69(23):9065-9072.
26. Kurzweil R. The singularity is near: when humans transcend biology. New York, NY: Viking, 2005; 56-72.
27. Corporate law: offshoring your lawyer. The Economist, December 18, 2010; 132.
28. Hagel J, Brown JS. The only sustainable edge: why business strategy depends on productive friction and dynamic specialization. Boston, Mass: Harvard Business School Press, 2005; 17-18, 279, 299.
29. Liang Y, Diehn M, Watson N, et al. Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme. Proc Natl Acad Sci U S A 2005;102(16):5814-5819. (Pubitemid 40559642)
30. Gladwell M. What the dog saw: and other adventures. New York, NY: Back Bay Books/Little Brown, 2009; 221.
31. Nielsen M. The new Einsteins will be scientists who share. Wall Street Journal, October 29-30, 2011; C3.
32. Kauffman S. Investigations. New York, NY: Oxford University Press, 2000; 142-144.
33. Hey T. The next scientific revolution. Harv Bus Rev 2010;88(11):56-63, 150.
34. Cancer genome atlas: functional assessment of somatic mutations in glioblastoma (TCGA). Memorial Sloan-Kettering Cancer Center Web site. http://cbio.mskcc/orgcancergenomics/gbm/mutations. Accessed April 20, 2011.
35. Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002;2(6):442-454.
36. Starr P. The social transformation of American medicine. New York, NY: Basic Books, 1982; 12-15.